readthroughSign in
CompanyGLUENasdaqBoston, MA

Monte Rosa Therapeutics, Inc

Monte Rosa Therapeutics develops molecular glue degrader small molecules targeting autoimmune, inflammatory, and oncology diseases.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 3Latest story